Cox, Donna S
GlaxoSmithKline (United States)
2 papers on CoChatORCID 0000-0003-4650-2877
Most cited papers
- Verified
Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial.
Infante, J. R., Fecher, L. A., Falchook, G. S., Nallapareddy, S., Gordon, M. S., Becerra, C., DeMarini, D. J., Cox, D. S., Xu, Y., Morris, S. R., et al. (2012) · The Lancet Oncology
Melanoma and MAPK PathwaysProtein Tyrosine Phosphatases
Cited by 552
- Verified
The rate of absorption and relative bioavailability of caffeine administered in chewing gum versus capsules to normal healthy volunteers
Kamimori, G. H., Karyekar, C. S., Otterstetter, R., Cox, D. S., Balkin, T. J., Belenky, G. L., & Eddington, N. D. (2002) · International Journal of Pharmaceutics
Coffee research and impactsDrug Solubulity and Delivery Systems
Cited by 449
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free